67.63MMarket Cap-0.52P/E (TTM)
5.600High4.730Low61.96KVolume4.890Open4.890Pre Close310.90KTurnover1.48%Turnover RatioLossP/E (Static)13.34MShares19.99952wk High0.57P/B21.21MFloat Cap4.57552wk Low--Dividend TTM4.18MShs Float171.799Historical High--Div YieldTTM17.79%Amplitude4.575Historical Low5.017Avg Price1Lot Size
OnKure Therapeutics Stock Forum
Onkure Therapeutics Inc - Oki-219 Well Tolerated With No Hyperglycemia and Only Grade 1 Traes
SC 13G: Statement of acquisition of beneficial ownership by individuals-Kenneth Griffin(9.9%),Citadel Advisors LLC(9.8%), etc.
SEC 17:29
SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Asset Management, LP(14.98%),Bihua Chen(14.98%), etc.
SEC 16:24
SC 13G: Statement of acquisition of beneficial ownership by individuals-Samsara BioCapital, L...
No comment yet